Effects of Metoprolol on Exercise Hemodynamics in Patients With Obstructive Hypertrophic Cardiomyopathy.

[1]  T. B. Rasmussen,et al.  Randomized Trial of Metoprolol in Patients With Obstructive Hypertrophic Cardiomyopathy. , 2021, Journal of the American College of Cardiology.

[2]  S. Ommen,et al.  Hypertrophic cardiomyopathy: a practical approach to guideline directed management , 2021, The Lancet.

[3]  S. Solomon,et al.  Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial , 2020, The Lancet.

[4]  B. Borlaug,et al.  Performance and Interpretation of Invasive Hemodynamic Exercise Testing. , 2020, Chest.

[5]  B. Borlaug,et al.  The Role of the Pericardium in Heart Failure: Implications for Pathophysiology and Treatment. , 2019, JACC. Heart failure.

[6]  A. Goda,et al.  Effects of body position during cardiopulmonary exercise testing with right heart catheterization , 2018, Physiological reports.

[7]  C. Hassager,et al.  The Influence of Age on Hemodynamic Parameters During Rest and Exercise in Healthy Individuals. , 2017, JACC. Heart failure.

[8]  L. Axel,et al.  The Mitral Valve in Obstructive Hypertrophic Cardiomyopathy: A Test in Context. , 2016, Journal of the American College of Cardiology.

[9]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.

[10]  V. V. van Empel,et al.  Effects of healthy aging on the cardiopulmonary hemodynamic response to exercise. , 2014, The American journal of cardiology.

[11]  B. Borlaug,et al.  Invasive hemodynamic characterization of heart failure with preserved ejection fraction. , 2014, Heart failure clinics.

[12]  M. Yacoub,et al.  Patterns of Disease Progression in Hypertrophic Cardiomyopathy: An Individualized Approach to Clinical Staging , 2012, Circulation. Heart failure.

[13]  G. Boriani,et al.  Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy. , 2009, The American journal of cardiology.

[14]  S. Ommen,et al.  The relationship of left atrial volume and left atrial pressure in patients with hypertrophic cardiomyopathy: an echocardiographic and cardiac catheterization study. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[15]  L. Køber,et al.  Left ventricular filling pressure estimation at rest and during exercise in patients with severe aortic valve stenosis: comparison of echocardiographic and invasive measurements. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[16]  B. Gersh,et al.  Effect of septal ablation on myocardial relaxation and left atrial pressure in hypertrophic cardiomyopathy an invasive hemodynamic study. , 2008, JACC. Cardiovascular interventions.

[17]  M. Link,et al.  Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction , 2006, Circulation.

[18]  Harry Rakowski,et al.  Enlarged left atrial volume in hypertrophic cardiomyopathy: a marker for disease severity. , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[19]  Yves Lecarpentier,et al.  New formula for predicting mean pulmonary artery pressure using systolic pulmonary artery pressure. , 2004, Chest.

[20]  T. Kato,et al.  Myocardial velocity gradient as a noninvasively determined index of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy. , 2003, Journal of the American College of Cardiology.

[21]  B. Maron,et al.  Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. , 2003, The New England journal of medicine.

[22]  D. Kass,et al.  Marked discordance between dynamic and passive diastolic pressure-volume relations in idiopathic hypertrophic cardiomyopathy. , 1996, Circulation.

[23]  I. Belenkie,et al.  Exercise capacity in hypertrophic cardiomyopathy. Role of stroke volume limitation, heart rate, and diastolic filling characteristics. , 1995, Circulation.

[24]  F. Flachskampf,et al.  Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus. , 1995, Circulation.

[25]  S. Nakatani,et al.  Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy. , 1995, Journal of the American College of Cardiology.

[26]  M. Shimizu,et al.  Left atrial afterload mismatch in hypertrophic cardiomyopathy. , 1991, The American journal of cardiology.

[27]  R. Bonow,et al.  Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy. , 1987, Journal of the American College of Cardiology.

[28]  W J Keon,et al.  The relationship between pericardial pressure and right atrial pressure: an intraoperative study. , 1986, Circulation.

[29]  O. Hess,et al.  Diastolic function in hypertrophic cardiomyopathy: effects of propranolol and verapamil on diastolic stiffness. , 1983, European heart journal.

[30]  H. Krayenbuehl,et al.  Reappraisal of the effect of acute betablockade on left ventricular filling dynamics in hypertrophic obstructive cardiomyopathy. , 1981, European heart journal.

[31]  R. Swanton,et al.  Effects of propranolol on myocardial oxygen consumption, substrate extraction, and haemodynamics in hypertrophic obstructive cardiomyopathy. , 1980, British heart journal.

[32]  J. Sanderson,et al.  Left ventricular filling in hypertrophic cardiomyopathy. An angiographic study. , 1977, British heart journal.

[33]  B. Lewis,et al.  Left ventricular volumes and compliance in hypertrophic cardiomyopathy. , 1974, Chest.

[34]  E. W. Hancock,et al.  Hypertrophic subaortic stenosis. Clinical and hemodynamic effects of long-term propranolol therapy. , 1973, The American journal of cardiology.

[35]  R. Gramiak,et al.  Long-term propranolol therapy in muscular subaortic stenosis. , 1970, British heart journal.

[36]  E. W. Hancock,et al.  Muscular Subaortic Stenosis: Prevention of Outflow Obstruction with Propranolol , 1968, Circulation.

[37]  J. Ross,et al.  Idiopathic hypertrophic subaortic stenosis. Effects of changes in heart rate on the severity of obstruction to left ventricular outflow. , 1967, The American journal of cardiology.

[38]  E. Braunwald,et al.  Amelioration of Angina Pectoris in Idiopathic Hypertrophic Subaortic Stenosis with Beta‐Adrenergic Blockade , 1967, Circulation.

[39]  C. Lambrew,et al.  Idiopathic Hypertrophic Subaortic Stenosis: I. A Description of the Disease Based Upon an Analysis of 64 Patients , 1964, Circulation.

[40]  J. Ross,et al.  The Circulatory Response of Patients with Idiopathic Hypertrophic Subaortic Stenosis to Nitroglycerin and to the Valsalva Maneuver , 1964, Circulation.

[41]  E. Braunwald,et al.  Hemogynamic alterations in idiopathic hypertrophic subaortic stenosis induced by sympathomimetic drugs. , 1962, The American journal of cardiology.

[42]  S. Silver,et al.  Heart Failure , 1937, The New England journal of medicine.

[43]  M. Maron,et al.  Controversies in cardiovascular medicine Pharmacological treatment options for hypertrophic cardiomyopathy : high time for evidence , 2012 .

[44]  Bing H. Tang.  Crossover trials. , 2009, Journal of neurosurgery.

[45]  I. Palacios,et al.  Obstructive intramural coronary amyloidosis : a distinct phenotype of cardiac amyloidosis that can cause acute heart failure , 2006 .

[46]  J. Parker,et al.  Hemodynamics at rest and during supine and sitting bicycle exercise in normal subjects. , 1978, The American journal of cardiology.